Generally, the two methods identified the same population distributions of characteristics that were associated with psychiatric morbidity though nearly as many non-cases as cases received sDAS medication (46.4% vs. Overall, 19% of respondents were defined as ‘cases’ and 14.3% were taking sDAS medication. The psychiatric morbidity of 7,489 respondents was assessed using the GHQ-12 and self-reported use of medication for stress, anxiety and depression (sDAS medication). This study used data from two recent population-wide health surveys in Northern Ireland, a country (UK) with free health services and no prescription charges. To compare estimates of psychiatric morbidity derived by a validated screening instrument of psychiatric morbidity and a self-reported medication uptake measure. However, it is not known how this compares with estimates derived from population screening tools. Uptake of psychotropic medication has been previously used as a proxy for assessing the prevalence of population mental health morbidity.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |